Heidi Anne Duerr, MPH

Articles by Heidi Anne Duerr, MPH

Laparoscopy has been shown to be a safe and effective option for many diverse pelvic organ diseases, but how does the procedure fare during pregnancy? Due to the absence of large, comparative studies in pregnancy, there has been no definitive answer to this question. Now, researchers from Korea have found that laparoscopic surgeries can be safely used in women who are pregnant. Their results have been published in The Australian and New Zealand Journal of Obstetrics and Gynaecology.

Fatigue, which can plague patients’ years after cancer treatment has ended, may be the result of inflammation. Now, a new study published in the Journal of Clinical Oncology has found that omega-3 may help reduce fatigue associated with inflammation in these patients.

Research has shown that glucocorticoid administration has a significant beneficial effect for preterm births, as it decreases the incidence of respiratory distress syndrome in infants delivered between 24 weeks and 34 weeks gestation, reduces the incidence of intraventricular hemorrhage, improves circulatory stability in premature infants, reduces the need for oxygen and ventilatory support, and reduces overall neonatal mortality.

Although more than 500,000 hysterectomies are performed annually in the U.S. to treat benign pelvic diseases, most outcome studies of the procedure look at clinical factors such as operation time, surgical complications, and hospital stays while ignoring patient satisfaction and quality of life issues. Now, a new study published in Obstetrics & Gynecology has found that patients who receive laparoscopic hysterectomy may fare better than those who receive abdominal hysterectomy.

Although uterine leiomyomas are benign tumors, its symptoms, including anemia, excessive vaginal bleeding, pelvic pain, pressure-related bowel and bladder dysfunction, recurrent miscarriage and preterm labor, can severely negatively impact patients’ quality of life. Since uterine leiomyomas are three to four times more common in African-American patients, and since African-American women have 10 times higher incidence of hypovitaminosis D than white women, researchers sought to explore the impact of vitamin D3 on uterine leiomyomas.

Ulipristal is a safe and effective option for women with uterine fibroids, according to two new studies published in the New England Journal of Medicine. In both studies, the oral selective progesterone receptor modulator was well-tolerated, rapidly reduced excessive bleeding, and decreased the size of uterine fibroids.

Latest Updated Articles